<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02512211</url>
  </required_header>
  <id_info>
    <org_study_id>VALIDATION</org_study_id>
    <secondary_id>VALIDATION</secondary_id>
    <nct_id>NCT02512211</nct_id>
  </id_info>
  <brief_title>Validation of Questionnaires HAL and HEP</brief_title>
  <acronym>VALIDATION</acronym>
  <official_title>Spanish Validation of &quot;Haemophilia Activities List&quot; (HAL) and &quot;Specific Sport Scale&quot; (HEP-Test-Q) Questionnaires</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universidad Católica San Antonio de Murcia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universidad Católica San Antonio de Murcia</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Spanish Validation of HAL and HEP questionnaire by double translation
      (English-Spanish-English), with a pilotage pediatric patients with hemophilia and adults and
      parents of children with hemophilia. The final validity will be obtained with a sample of
      60-100 patients with hemophilia
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Validation of the Spanish hemophilia specific questionnaires: HAL and HEP (adult version
      version version children and parents). To do this, there will be a double inverse
      translation, a pilotage of validity and clarity with a small sample of subjects and analysis
      of reliability and validity with more than 100 patients and parents of children with
      hemophilia to complete the validation.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>October 2015</start_date>
  <completion_date type="Anticipated">October 2016</completion_date>
  <primary_completion_date type="Actual">May 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Translation of the original questionnaire (English) to Spanish</measure>
    <time_frame>1 day (Screening visit)</time_frame>
    <description>Three health experienced in the treatment of hemophilia and knowledge of English, translated into Spanish the HAL and HEP questionnaire.
Two native speakers (English and Spanish), reverse-translate the original text of the HAL and HEP questionnaires and the text translated by the Spanish health</description>
  </primary_outcome>
  <primary_outcome>
    <measure>the translated version of the questionnaire</measure>
    <time_frame>1 day (Screening visit)</time_frame>
    <description>5 patients with hemophilia under 16, 5 patients with hemophilia adults , and 5 parents of children with hemophilia enrolled randomly will participate in the pilotage.
The clarity of the questions in Spanish translated version and the relevance of each of the items of the questionnaires will be evaluated.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Sending the questionnaire to a large sample of patients for final validation</measure>
    <time_frame>1 day (Screening visit)</time_frame>
    <description>40 hemophilia patients under 16 years old, 60 adult patients with hemophilia and 60 parents of children with hemophilia will participate in the pilotage.
The validity and reliability of the Spanish version translated from the questionnaires will be assessed.</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Haemophilia</condition>
  <arm_group>
    <arm_group_label>Patients adults</arm_group_label>
    <description>Sample of patients with haemophilia over 18 years of age that will participate in piloting of reliability and validity of the Spanish version of the HAL and HEP questionnaires</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Children with haemophilia</arm_group_label>
    <description>Sign hemophilia patients under 18 years of age that will participate in piloting of reliability and validity of the Spanish version of the HAL and HEP questionnaires</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Parents of children with haemophilia</arm_group_label>
    <description>Sample of parents of children with hemophilia under 18 years of age that will participate in piloting of reliability and validity of the Spanish version of the HAL and HEP questionnaires</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with haemophilia and parents of children with hemophilia around the country that
        will participate in study.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with hemophilia A and B

          -  Parents of children with hemophilia A and B, under 18

          -  Patients who have previously signed the informed consent document

        Exclusion Criteria:

          -  Patients with other congenital coaghulopatías (eg, Von Willebrand's disease)

          -  Patients with cognitive impairment, or oral or written understanding
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>8 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>RUBEN CUESTA-BARRIUSO, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universidad Católica San Antonio</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Universidad de Murcia</name>
      <address>
        <city>Murcia</city>
        <zip>30100</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universidad Católica San Antonio, Murcia</name>
      <address>
        <city>Murcia</city>
        <zip>30107</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>June 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 22, 2014</study_first_submitted>
  <study_first_submitted_qc>July 29, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 30, 2015</study_first_posted>
  <last_update_submitted>June 30, 2016</last_update_submitted>
  <last_update_submitted_qc>June 30, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 1, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universidad Católica San Antonio de Murcia</investigator_affiliation>
    <investigator_full_name>Rubén Cuesta-Barriuso, PhD</investigator_full_name>
    <investigator_title>PhD</investigator_title>
  </responsible_party>
  <keyword>Hemophilia</keyword>
  <keyword>Validation</keyword>
  <keyword>Questionnaires</keyword>
  <keyword>Activities</keyword>
  <keyword>Sport</keyword>
  <keyword>Patients</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemophilia A</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

